Sysmex (OTCMKTS:SSMXY) Shares Gap Up - Should You Buy?

Key Points

• Shares gapped up pre-market from $8.46 to an $8.81 open and last traded around $8.605 with roughly 19,600 shares traded.
• Analyst sentiment cooled: Citigroup downgraded Sysmex from "strong-buy" to "hold," and the consensus rating is currently "Hold" (one Buy, two Holds).
• Solid quarter and valuation metrics: Sysmex beat quarterly EPS ($0.15 vs $0.14) and revenue ($837.3M vs $820.0M); the company has a $5.34B market cap, a P/E of ~17.7, strong liquidity (quick ratio 2.44) and low debt (D/E 0.12).

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report)'s share price gapped up before the market opened on Thursday . The stock had previously closed at $8.46, but opened at $8.81. Sysmex shares last traded at $8.6050, with a volume of 19,589 shares traded.

Wall Street Analyst Weigh In

Separately, Citigroup lowered shares of Sysmex from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 16th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold".

Sysmex Price Performance

The stock has a fifty day moving average of $9.17 and a 200-day moving average of $10.30. The company has a quick ratio of 2.44, a current ratio of 3.33 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $5.34 billion, a P/E ratio of 17.69 and a beta of 1.14.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its quarterly earnings data on Thursday, February 12th. The company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of $0.14 by $0.01. The firm had revenue of $837.32 million for the quarter, compared to analyst estimates of $819.99 million. Sysmex had a net margin of 8.86% and a return on equity of 9.27%. Equities analysts predict that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation OTCMKTS: SSMXY is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex's product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company's core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.